PHIA Koninklijke Philips N.V.

Philips once again ranked among the world’s top global companies for its commitment to action on climate change

Philips once again ranked among the world’s top global companies for its commitment to action on climate change

January 20, 2020

  • Philips on CDP Climate Change A-list for seventh year running
  • Philips recognized for its actions to reduce emissions, mitigate climate risks and develop the low-carbon economy

Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has once again been placed on the CDP Climate Change A List [1], making this the seventh consecutive year it has achieved a CDP A-list ranking for its leadership in corporate climate action.

CDP is a not-for-profit organization that runs a global disclosure system for investors, companies, cities, states and regions to help manage their environmental impact. The organization assesses a company’s environmental impact disclosure data against a scoring methodology that rates them on a scale of A to D, with A being the highest possible achievement. Based on its 2019 disclosure to CDP, Philips has been recognized for its actions during the last reporting year to reduce emissions, mitigate climate risks and develop the low-carbon economy.

“The results of the World Economic Forum’s latest , that environmental threats rank in the top five risks for the coming decade, confirm the concerns we are all having about the devastating effects of climate change,” said Frans van Houten, CEO of Royal Philips. “That’s why Philips is constantly innovating, not only to deliver affordable outcome-focused health technology solutions that will help to achieve universal health coverage, but also to make sure we do it in a sustainable way that minimizes our carbon footprint and natural resource consumption.”

To achieve its vision of making the world healthier and more sustainable through innovation with the goal of improving the lives of 3 billion people a year by 2030, Philips focuses its activities on three key UN Sustainable Development Goals –  SDG3 health and wellbeing for all, SDG12 sustainable consumption and production, and SDG13 action on climate change. The company is committed to having 95% of its business revenues linked to these SDGs by the end of 2020.

Philips’ drive for affordable and effective healthcare delivery is based on a shift from volume-based care (payment per procedure) to value-based care (the best health outcomes for a given cost), using advanced digital technologies such as artificial intelligence and predictive analytics to improve diagnostic accuracy and treatment efficacy, enhance population health management, and maximize the efficient use of resources.

Its strategy for sustainability and action on climate change is embedded in its business model on both the procurement side – for example, through the purchase of green energy – and on the customer side through implementation of circular economy solutions. Philips is now powering 100% of its Netherlands operations with renewable energy, matching the 100% renewable energy target already achieved in the company’s US operations. The company is also on track to deliver on the circular economy commitment it made at the 2018 WEF Annual Meeting that by 2020 the company will take back and repurpose all the large medical systems that its customers are prepared to return to it. As witnessed by CEO Frans van Houten’s co-chairmanship of PACE (Platform for Accelerating the Circular Economy), the circular economy is central to Philips’ vision of making the world healthier and more sustainable through innovation.

“Congratulations to the companies that achieved a position on CDP’s A List this year, for leading in environmental performance and transparency,” said Paul Simpson, CEO of CDP. “The scale of the business risks from the climate emergency, deforestation and water insecurity are vast – as are the opportunities from addressing them – and it’s clear the private sector has a vital role to play at this critical time. The A List companies are leading the market in corporate sustainability, tackling environmental risks and setting themselves up to thrive in tomorrow’s economy.”

CDP’s scoring methodology assesses companies on the comprehensiveness of their disclosure, their awareness and management of environmental risks, and their demonstration of best practices associated with environmental leadership, such as setting ambitious and meaningful targets.

Information on Philips’ sustainability strategy and its ‘Healthy people, sustainable planet’ program can be found .

[1]  The Climate Change A List is published by CDP each year, alongside A Lists for leadership on protecting forests and water security. The full list of companies that made this year’s CDP Climate Change A List is available, along with other publicly available company scores, at .

For further information, please contact:

Joost Maltha

Philips Global Press Office

Tel.: 6

E-mail:

Ben Zwirs

Philips Global Press Office

Tel.: 6

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

 

Attachments

EN
20/01/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation ...

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE’s technologies have the potential to significantly increase adoption of corona...

 PRESS RELEASE

Philips reiterates timing of 2026 outlook

Philips reiterates timing of 2026 outlook December 4, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the company’s previously communicated schedule. As previously guided, the company expects continued performance improvement with sequential comparable sales growth, expanded margins (despite tariff headwinds) and strong cashflow. The company continues to expect comparative sales growth to accelerate sequentially in 2026 towards mid-single-digit gro...

 PRESS RELEASE

Philips expands commercial availability of world’s first real-time AI-...

Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy December 1, 2025 Commercial availability expanded across Europe and the United StatesReal-time AI-enabled 3D device visualization powered by light instead of X-ray, improving navigation in complex endovascular proceduresLumiGuide seamlessly integrates with Azurion, Philips’ proven, world-leading image-guided therapy platform designed to drive procedural innovation across clinical domains Amsterdam, the Netherlands and Chicago, USA – (NYSE: PHG, AEX: PH...

 PRESS RELEASE

Philips launches Verida, world’s first detector-based spectral CT powe...

Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision November 30, 2025 Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1]CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4] Amsterdam, the Netherlands and Chicago, USA – At RSNA 2025, (NYSE: PHG, AEX: PHIA), a global leader in health techno...

 PRESS RELEASE

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MR...

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform November 30, 2025 Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1] Amsterdam, the Netherlands, and Chicago, USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled BlueSeal Horizon [1], an entirely new 3.0T MRI innovation platform that includes the industry’s first helium-free 3.0T magnet at . A pivotal advance in MRI innovation, helium-free [2] 3.0T is a major scientific achievement set to have s...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch